Pledge Tx

Foundation date

14/05/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Pledge Therapeutics discovers and develops small molecule drugs that demonstrate target engagement and therefore deliver durable disease-modifying effect. Our goal is to bring drug candidates with novel mechanisms of action to a stage more suitable for strategic co-development.

Upcoming events

Latest news

  • Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

    6 hours ago

  • Novalis Biotech invests in Rarity Bioscience's ultra sensitive genomics technology

    1 day ago

  • Fat creates an ideal environment for metastatic breast tumors

    1 day ago